ArticleGland surgery2026
Robotic nipple-sparing mastectomy after periareolar incision: a surgical technical approach to subareolar dissection in a previously operated field.
Article in Gland surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nipple-sparing mastectomy (NSM) after a prior periareolar incision is technically demanding because fibrosis, altered tissue planes, and possible vascular compromise around the nipple-areola complex (NAC) may increase the difficulty of subareolar dissection. Although robotic nipple-sparing mastectomy (R-NSM) has been reported as a minimally invasive option, its specific role in re-operative subareolar fields remains uncertain. This surgical technical report describes R-NSM performed with the da Vinci Xi system in a 51-year-old woman who previously underwent diagnostic lumpectomy through a periareolar incision for atypical ductal hyperplasia, followed by an indication for additional resection after ductal carcinoma in situ with microinvasion was identified. A 3.5-cm mid-axillary incision was used for access with a GelPOINT Mini platform. The key technical elements were lateral access without reopening the periareolar incision, low-pressure CO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.